CK Life Sciences Int'l. (Holdings) Dirección
Dirección controles de criterios 3/4
CK Life Sciences Int'l. (Holdings)'s El consejero delegado es Alan Abel Yu , nombrado en Sep 2020, tiene un mandato de 3.33 años. la remuneración anual total es HK$14.36M , compuesta por 74.1% salario y 25.9% primas, incluidas acciones y opciones de la empresa. posee directamente 0.023% de las acciones de la empresa, por valor de HK$1.33M . La antigüedad media del equipo directivo y del consejo de administración es de 13.4 años y 8.8 años respectivamente.
Información clave
Alan Abel Yu
Chief Executive Officer (CEO)
HK$14.4m
Compensación total
| Porcentaje del salario del CEO | 74.1% |
| Permanencia del CEO | 3.6yrs |
| Participación del CEO | 0.02% |
| Permanencia media de la dirección | 13.6yrs |
| Promedio de permanencia en la Junta Directiva | 9.1yrs |
Actualizaciones recientes de la dirección
Recent updates
CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky
Mar 26
Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly
Sep 27Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?
Sep 16Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)
Aug 21These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively
Apr 14CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry
Mar 18If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns
Feb 01
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?
Jan 04CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet
Dec 09We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide
Nov 18Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | HK$17m |
| Sep 30 2023 | n/a | n/a | HK$61m |
| Jun 30 2023 | n/a | n/a | HK$104m |
| Mar 31 2023 | n/a | n/a | HK$118m |
| Dec 31 2022 | HK$14m | HK$11m | HK$132m |
| Sep 30 2022 | n/a | n/a | HK$130m |
| Jun 30 2022 | n/a | n/a | HK$128m |
| Mar 31 2022 | n/a | n/a | HK$145m |
| Dec 31 2021 | HK$14m | HK$10m | HK$163m |
| Sep 30 2021 | n/a | n/a | HK$150m |
| Jun 30 2021 | n/a | n/a | HK$138m |
| Mar 31 2021 | n/a | n/a | HK$132m |
| Dec 31 2020 | HK$14m | HK$11m | HK$125m |
| Sep 30 2020 | n/a | n/a | HK$112m |
| Jun 30 2020 | n/a | n/a | HK$98m |
| Mar 31 2020 | n/a | n/a | HK$140m |
| Dec 31 2019 | HK$14m | HK$10m | HK$182m |
| Sep 30 2019 | n/a | n/a | HK$223m |
| Jun 30 2019 | n/a | n/a | HK$263m |
| Mar 31 2019 | n/a | n/a | HK$263m |
| Dec 31 2018 | HK$13m | HK$10m | HK$263m |
| Sep 30 2018 | n/a | n/a | HK$261m |
| Jun 30 2018 | n/a | n/a | HK$259m |
| Mar 31 2018 | n/a | n/a | HK$259m |
| Dec 31 2017 | HK$12m | HK$9m | HK$258m |
Compensación vs. Mercado: Alan Abel($USD1.84M) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD486.61K).
Compensación vs. Ingresos: Alan Abelha sido coherente con los resultados de la empresa en el último año.
CEO
Alan Abel Yu (67 yo)
3.6yrs
Permanencia
HK$14,360,000
Compensación
Mr. Ying Choi Yu, also known as Alan Abel, has been the Chief Executive Officer at CK Life Sciences Int'l., (Holdings) Inc. since September 1, 2020 and serves as its Vice President and Executive Director....
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 22yrs | HK$125.00k | 0.023% HK$ 877.5k | |
| CEO, VP & Executive Director | 3.6yrs | HK$14.36m | 0.023% HK$ 877.5k | |
| President & Executive Director | 21.8yrs | HK$2.85m | 0.065% HK$ 2.4m | |
| Senior VP | no data | HK$1.63m | 0.023% HK$ 877.5k | |
| VP, Chief Scientific Officer & Executive Director | 5.4yrs | HK$5.84m | sin datos | |
| Chief Financial Officer | no data | sin datos | sin datos | |
| Chief Operating Officer of Global Operations | no data | sin datos | sin datos | |
| Chief Manager of Human Resources & Administration | no data | sin datos | sin datos | |
| Legal Counsel | no data | sin datos | sin datos | |
| Chief Corporate Affairs Officer | no data | sin datos | sin datos | |
| Company Secretary | 22.3yrs | sin datos | sin datos | |
| Chief Executive Officer of Regenal Investments Pty Limited | no data | sin datos | sin datos |
13.6yrs
Permanencia media
62yo
Promedio de edad
Equipo directivo experimentado: 775El equipo directivo de la empresa es veterano y experimentado (13.3 años de antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 22yrs | HK$125.00k | 0.023% HK$ 877.5k | |
| CEO, VP & Executive Director | no data | HK$14.36m | 0.023% HK$ 877.5k | |
| President & Executive Director | no data | HK$2.85m | 0.065% HK$ 2.4m | |
| Senior VP | no data | HK$1.63m | 0.023% HK$ 877.5k | |
| VP, Chief Scientific Officer & Executive Director | 5.4yrs | HK$5.84m | sin datos | |
| Independent Non-Executive Director | 21.8yrs | HK$100.00k | 0.0021% HK$ 78.0k | |
| Co-Chairman of Vitaquest International LLC | no data | sin datos | sin datos | |
| Non-Executive Director | 22yrs | HK$75.00k | 0.011% HK$ 409.3k | |
| Independent Non-executive Director | 9.1yrs | HK$155.00k | sin datos | |
| Independent Non-Executive Director | 3.8yrs | HK$188.00k | sin datos | |
| Independent Non-Executive Director | 4.8yrs | HK$205.00k | sin datos |
9.1yrs
Permanencia media
71yo
Promedio de edad
Junta con experiencia: La junta directiva de 775 se considera experimentada (8.8 años de antigüedad promedio).